We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Jerini and Lev Race for FDA Approval to Treat HAE
Jerini and Lev Race for FDA Approval to Treat HAE
June 23, 2008
Jerini plans to submit a complete response to a not-approvable letter it received last week for Icatibant as a treatment for hereditary angioedema (HAE).